{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:30:30Z","timestamp":1786357830674,"version":"build-2736575974"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Dementia represents a major global health challenge, and preventive strategies remain limited. Observational studies have suggested a possible association between herpes zoster vaccination (HZV) and dementia risk, although the influence of vaccine type and dose regimen remains unclear. Methods: PubMed, Embase, and Web of Science were searched through January 2026. The primary random-effects meta-analysis included one adjusted estimate per independent study or data-source cluster. Quasi-experimental and correlated secondary estimates were reported separately, and alternative-estimate and leave-one-out analyses retained independent statistical units. The protocol was registered in PROSPERO (CRD420261326042). Results: Fourteen reports representing 13 studies were included. HZV was associated with a lower dementia risk in the primary analysis of five independent data sources (ratio estimate = 0.72; 95% CI: 0.65\u20130.81; I2 = 97.1%), with similar sensitivity results (0.70\u20130.76). Two regression-discontinuity studies reported eligibility-associated absolute reductions in dementia diagnosis of 1.3 and 1.8 percentage points. Two direct vaccine comparisons favored the recombinant zoster vaccine (RZV; Shingrix) over the live attenuated vaccine (ZVL; Zostavax) (RMTL ratio = 0.83; 95% CI: 0.80\u20130.87; RR = 0.82; 95% CI: 0.69\u20130.98). The only direct dose comparison favored two or more RZV doses over one dose (RR = 0.81; 95% CI: 0.74\u20130.88). Active-comparator associations were generally attenuated, whereas age- and subtype-specific findings varied. These secondary findings were exploratory. Conclusions: HZV was associated with lower dementia risk in observational studies, with directionally consistent quasi-experimental findings. Direct evidence suggested potentially stronger inverse associations for RZV and complete vaccination, but was based on few independent data sources. Substantial heterogeneity and residual confounding preclude causal interpretation, and further prospective or randomized evidence is needed.<\/jats:p>","DOI":"10.3390\/vaccines14080685","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:24:53Z","timestamp":1786353893000},"page":"685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Herpes Zoster Vaccination and Dementia Risk: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"14","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-9713","authenticated-orcid":false,"given":"Quanman","family":"Hu","sequence":"additional","affiliation":[{"name":"College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Wei","sequence":"additional","affiliation":[{"name":"Huaiyang District Center for Disease Control and Prevention, Zhoukou 466700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-0310","authenticated-orcid":false,"given":"Shuaiyin","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Public Health, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Huang, Y., Li, X., Liu, Z., Huo, J., Guo, J., Chen, Y., Chen, Y., and Chen, R. (2022). Projections of the Economic Burden of Care for Individuals with Dementia in Mainland China from 2010 to 2050. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263077"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and Microglial Cells as the Modulators of Neuroinflammation in Alzheimer\u2019s Disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella Zoster Virus Infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0042-6822(90)90152-H","article-title":"Varicella-Zoster Virus Infection of Human Astrocytes, Schwann Cells, and Neurons","volume":"179","author":"Assouline","year":"1990","journal-title":"Virology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"afaf331","DOI":"10.1093\/ageing\/afaf331","article-title":"Association between Vaccinations and Risk of Dementia: A Systematic Review and Meta-Analysis","volume":"54","author":"Maggi","year":"2025","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against Herpes Zoster and Postherpetic Neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10072-023-07038-7","article-title":"The Association between Varicella Zoster Virus and Dementia: A Systematic Review and Meta-Analysis of Observational Studies","volume":"45","author":"Gao","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lo, C.K.-L., Mertz, D., and Loeb, M. (2014). Newcastle-Ottawa Scale: Comparing Reviewers\u2019 to Authors\u2019 Assessments. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-45"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta-Analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring Inconsistency in Meta-Analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126673","DOI":"10.1016\/j.vaccine.2024.126673","article-title":"Recombinant Zoster Vaccine and the Risk of Dementia","volume":"46","author":"Tang","year":"2025","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41591-025-03972-5","article-title":"Varicella-Zoster Virus Reactivation and the Risk of Dementia","volume":"31","author":"Polisky","year":"2025","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-221231","article-title":"The Impact of Routine Vaccinations on Alzheimer\u2019s Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study Using Propensity Score Matching","volume":"95","author":"Harris","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e088064","DOI":"10.1002\/alz.088064","article-title":"Recombinant Zoster Vaccine and Reduced Risk of Dementia: Matched-Cohort Study Using Large-Scale Electronic Health Records and Machine Learning Methodology","volume":"20","author":"Schwab","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1002\/trc2.12293","article-title":"Reduced Dementia Incidence after Varicella Zoster Vaccination in Wales 2013\u20132020","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement.-Transl. Res. Clin. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax Vaccination and Risk of Developing Dementia: A Nested Case-Control Study-Results from the UK Biobank Cohort","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Scherrer, J.F., Salas, J., Wiemken, T.L., Hoft, D.F., Jacobs, C., and Morley, J.E. (2021). Impact of Herpes Zoster Vaccination on Incident Dementia: A Retrospective Study in Two Patient Cohorts. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0257405"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lophatananon, A., Carr, M., Mcmillan, B., Dobson, C., Itzhaki, R., Parisi, R., Ashcroft, D.M., and Muir, K.R. (2023). The Association of Herpes Zoster and Influenza Vaccinations with the Risk of Developing Dementia: A Population-Based Cohort Study within the UK Clinical Practice Research Datalink. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16768-4"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","article-title":"A Natural Experiment on the Effect of Herpes Zoster Vaccination on Dementia","volume":"641","author":"Eyting","year":"2025","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.2025.5013","article-title":"Herpes Zoster Vaccination and Dementia Occurrence","volume":"333","author":"Pomirchy","year":"2025","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The Recombinant Shingles Vaccine Is Associated with Lower Risk of Dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-025-01172-3","article-title":"Lower Risk of Dementia with AS01-Adjuvanted Vaccination against Shingles and Respiratory Syncytial Virus Infections","volume":"10","author":"Taquet","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jiac484","article-title":"Common Vaccines and the Risk of Incident Dementia: A Population-Based Cohort Study","volume":"227","author":"Douros","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jgs.17606","article-title":"Comparison of Rates of Dementia among Older Adult Recipients of Two, One, or No Vaccinations","volume":"70","author":"Wiemken","year":"2022","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11910-015-0534-4","article-title":"The Relationship between Herpes Zoster and Stroke","volume":"15","author":"Nagel","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The Active Comparator, New User Study Design in Pharmacoepidemiology: Historical Foundations and Contemporary Application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr. Epidemiol. Rep."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:47:10Z","timestamp":1786355230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["vaccines14080685"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14080685","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}